The effect of pegvisomant-induced serum IGF-I normalization on serum leptin levels in patients with acromegaly

Clinical Endocrinology

Volumn 59, Issue 2, 2003, Pages 168-174

  Parkinson, Craig ^a,g   Whatmore, A J ^b   Yates, A P ^c   Drake, W M ^d   Brabant, G ^e   Clayton, P E ^b   Trainer, P J ^f  

^a IPSWICH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e Meizinische Hochschule   (Germany)

^f CHRISTIE HOSPITAL   (United Kingdom)

^g IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN; LEPTIN; LEPTIN RECEPTOR; PEGVISOMANT; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOPHYSIS; INSULIN BLOOD LEVEL; LIPOLYSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ACROMEGALY; ADULT; AGED; BLOOD GLUCOSE; FEMALE; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; LINEAR MODELS; MALE; MIDDLE AGED; RECEPTORS, SOMATOTROPIN; STATISTICS, NONPARAMETRIC;

EID: 0042165851     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01795.x     Document Type: Article

References (42)

1. Bengtsson, B.A., Brummer, R.J., Eden, S. & Bosaeus, I. (1989) Body composition in acromegaly. Clinical Endocrinology, 30, 121-130.
2. de Boer, H., Blok, G.J., Voerman, H.J., De Vries, P.M. & van der Veen, E.A. (1992) Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis. Journal of Clinical Endocrinology and Metabolism, 75, 833-837.
3. Carro, E., Senaris, R., Considine, R.V., Casanueva, F.F. & Dieguez, C. (1997) Regulation of in vivo growth hormone secretion by leptin. Endocrinology, 138, 2203-2206.
4. Considine, R.V., Sinha, M.K., Heiman, M.L., Kriauciunas, A., Stephens, T.W., Nyce, M.R., Ohannesian, J.P., Marco, C.C., McKee, L.J., Bauer, T.L., Caro, J.F. (1996) Serum-immunoreactive leptin concentrations in normal-weight and obese humans. New England Journal of Medicine, 334, 292-295.
5. Cunningham, B.C., Ultsch, M., De Vos, A.M., Mulkerrin, M.G., Clauser, K.R. & Wells, J.A. (1991) Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science, 254, 821-825.
6. Dagogo-Jack, S., Fanelli, C., Paramore, D., Brothers, J. & Landt, M. (1996) Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes, 45, 695-698.
7. Damjanovic, S.S., Petakov, M.S., Raicevic, S., Micic, D., Marinkovic, J., Dieguez, C., Casanueva, F.E & Popovic, V. (2000) Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by transsphenoidal surgery. Journal of Clinical Endocrinology and Metabolism, 85, 147-154.
8. Davidson, M.B. (1987) Effect of growth hormone on carbohydrate and lipid metabolism. Endocrine Reviews, 8, 115-131.
9. Donahoo, W.T., Jensen, D.R., Yost, T.J. & Eckel, R.H. (1997) Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion. Journal of Clinical Endocrinology and Metabolism, 82, 4139-4143.
10. Fisker, S., Vahl, N., Hansen, T.B., Jorgensen, J.O., Hagen, C., Orskov, H. & Christiansen, J.S. (1997) Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year. Metabolism, 46, 812-817.
11. Florkowski, C.M., Collier, G.R., Zimmet, P.Z., Livesey, J.H., Espiner, E.A. & Donald, R.A. (1996) Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency. Clinical Endocrinology, 45, 769-773.
12. Fors, H., Matsuoka, H., Bosaeus, I., Rosberg, S., Wikland, K.A. & Bjarnason, R. (1999) Serum leptin levels correlate with growth hormone secretion and body fat in children. Journal of Clinical Endocrinology and Metabolism, 84, 3586-3590.
13. Gill, M.S., Toogood, A.A., Jones, J., Clayton, P.E. & Shalet, S.M. (1999) Serum leptin response to the acute and chronic administration of growth hormone (GH) to elderly subjects with GH deficiency. Journal of Clinical Endocrinology and Metabolism, 84, 1288-1295.
14. Grinspoon, S., Gulick, T., Askari, H., Landt, M., Lee, K., Anderson, E., Ma, Z., Vignati, L., Bowsher, R., Herzog, D. & Klibanski, A. (1996) Serum leptin levels in women with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism, 81, 3861-3863.
15. Isozaki, O., Tsushima, T., Miyakawa, M., Nozoe, Y., Demura, H. & Seki, H. (1999) Growth hormone directly inhibits leptin gene expression in visceral fat tissue in fatty Lucker rats. Journal of Endocrinology, 161, 511-516.
16. Janssen, Y.J., Frolich, M., Deurenberg, P. & Roelfsema, F. (1997) Serum leptin levels during recombinant human GH therapy in adults with GH deficiency. European Journal of Endocrinology, 137, 650-654.
17. Kolaczynski, J.W., Nyce, M.R., Considine, R.V., Boden, G., Nolan, J.J., Henry, R., Mudaliar, S.R., Olefsky, J. & Caro, J.E (1996) Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes, 45, 699-701.
18. Larsson, H. & Ahren, B. (1996) Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. Journal of Clinical Endocrinology and Metabolism, 81, 4428-4432.
19. van der Lely, A.J., Hutson, R.K., Trainer, P.J., Besser, G.M., Katznelson, L., Klibanski, A., Herman-Bonert, V., Melmed, S., Vance, M.L., Fred & P.U., Stewart, P.M., Friend, K.E., Clemmons, D.R., Johannsson, G., Stavrou, S., Cook, D.M., Phillips, L.S., Strasburger, C.J., Hackett, S., Zib, K.A., Davis, R.J., Scarlett, J.A. & Thorner, M.O. (2001) Long-term treatment of acromegaly with pegvisomant, a growth hormone antagonist. Lancet, 358, 1754-1759.
20. Lewandowski, K., Horn, R., O'Callaghan, C.J., Dunlop, D., Medley, G.F., O'Hare, P. & Brabant, G. (1999) Free leptin, bound leptin, and soluble leptin receptor in normal and diabetic pregnancies. Journal of Clinical Endocrinology and Metabolism, 84, 300-306.
21. Lissett, C.A., Clayton, P.E. & Shalet, S.M. (2002) The acute leptin response to GH. Journal of Clinical Endocrinology and Metabolism, 86, 4412-4415.
22. Lonnqvist, F., Arner, P., Nordfors, L. & Schalling, M. (1995) Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Medicine, 1, 950-953.
23. Mathews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
24. Miyakawa, M., Tsushima, T., Murakami, H., Isozaki, O., Demura, H. & Tanaka, I. (1998) Effect of growth hormone (GH) on serum concentrations of leptin: study in patients with acromegaly and GH deficiency. Journal of Clinical Endocrinology. and Metabolism, 83, 3476-3479.
25. Nystrom, F., Ekman, B., Osterlund, M., Lindstrom, T., Ohman, K.P. & Arnqvist, H.J. (1997) Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment. Clinical Endocrinology, 47, 191-198.
26. Ostlund, R.E. Jr, Yang, J.W., Klein, S. & Gingerich, R. (1996) Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. Journal of Clinical Endocrinology and Metabolism, 81, 3909-3913.
27. Popovic, V., Micic, D., Danjanovic, S., Zoric, S., Djurovic, M., Obradovic, S., Petakov, M., Dieguez, C. & Casanueva, F.F. (1998) Serum leptin and insulin concentrations in patients with insulinoma before and after surgery. European Journal of Endocrinology, 138, 86-88.
28. Saladin, R., De Vos, P., Guerre-Millo, M., Leturque, A., Girard, J., Staels, B. & Auwerx, J. (1995) Transient increase in obese gene expression after food intake or insulin administration. Nature, 377, 527-529.
29. Salomon, F., Cuneo, R.C., Hesp, R. & Sonksen, P.H. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
30. Segal, K.R., Landt, M. & Klein, S. (1996) Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes, 45, 988-991.
31. Shimizu, H., Shimomura, Y., Nakanishi, Y., Futawatari, T., Ohtani, K., Sato, N. & Mori, M. (1997) Estrogen increases in vivo leptin production in rats and human subjects. Journal of Endocrinology, 154, 285-292.
32. Slieker, L.J., Sloop, K.W., Surface, P.L., Kriauciunas, A., LaQuier, F., Manetta, J., Bue-Valleskey, J. & Stephens, T.W. (1996) Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. Journal of Biology Chemistry, 271, 5301-5304.
33. Tan, K.C., Tso, A.W. & Lam, K.S. (2001) Effect of Sandostatin LAR on serum leptin levels in patients with acromegaly. Clinical Endocrinology, 54, 31-35.
34. Tannenbaum, G.S., Gurd, W. & Lapointe, M. (1998) Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone. Endocrinology, 139, 3871-3875.
35. Thorner, M.O., Strasburger, C.J., Wu, Z., Straume, M., Bidlingmaier, M., Pezzoli, S.S., Zib, K., Scarlett, J.C. & Bennett, W.F. (1999) Growth hormone (GH) receptor blockade with a PEG-modified GH (B2036-PEG) lowers serum insulin-like growth factor-I but does not acutely stimulate serum GH. Journal of Clinical Endocrinology and Metabolism, 84, 2098-2103.
36. Tominaga, A., Arita, K., Kurisu, K., Uozumi, T., Migita, K., Eguchi, K.I., Ida, K, Kawamoto, H. & Mizoue, T. (1998) Effects of successful adenomectomy on body composition in acromegaly. Endocrine Journal, 45, 335-342.
37. Trainer, P.J., Drake, W.M., Katznelson, L., Freda, P.U., Herman-Bonert, V., van der Lely, A.J., Dimaraki, E.V., Stewart, P.M., Friend, K.E., Vance, M.L., Besser, G.M., Scarlett, J.A., Thorner, M.O., Parkinson, C., Klibanski, A., Powell, J.S., Barkan, A.L., Sheppard, M.C., Malsonado, M., Rose, D.R., Clemmons, D.R., Johannsson, G., Bengtsson, B.A., Stavrou, S., Kleinberg, D.L., Cook, D.M., Phillips, L.S., Bidlingmaier, M., Strasburger, C.J., Hackett, S., Zib, K., Bennett, W.F. & Davis, R.J. (2000) Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. New England Journal of Medicine, 342, 1171-1177.
38. Utriainen, T., Malmstrom, R., Makimattila, S. & Yki-Jarvinen, H. (1996) Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects. Diabetes, 45, 1364-1366.
39. Veldhuis, J.D., Iranmanesh, A., Ho, K.K., Waters, M.J., Johnson, M.L. & Lizarralde, G. (1991) Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. Journal of Clinical Endocrinology and Metabolism, 72, 51-59.
40. Wabitsch, M., Blum, W.F., Muche, R., Braun, M., Hube, F., Rascher, W., Heinze, E., Teller, W. & Hauner, H. (1997) Contribution of androgens to the gender difference in leptin production in obese children and adolescents. Journal of Clinical Investigation, 100, 808-813.
41. Williams, T., Berelowitz, M., Joffe, S.N., Thorner, M.O., Rivier, J., Vale, W. & Frohman, L.A. (1984) Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. New England Journal of Medicine, 311, 1403-1407.
42. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. & Friedman, J.M. (1994) Positional cloning of the mouse obee gene and its human homologue. Nature, 372, 425-432.